Executive health checkups sell doctor time, not test data

Is an executive health checkup worth the money?

Longetic keeps the lab reports from whichever route you take, and the two routes differ far more in price than in tests. A large blood panel bought directly costs $189 to $399, while executive physicals at top-ranked US hospitals cost $1,700 to $10,000 in a 2019 JAMA survey. The extra money buys physician time, a decision about which tests you need and same-day specialist access, so judge a package on those three things, not on its biomarker count.

The hardest number to find in American preventive medicine is the price of an executive physical. Most of the US programs we checked publish contents, duration and hospitality details and no figure, and only three print a price on their own pages. Every range circulating online comes either from two peer-reviewed surveys or from a clinic blog that cites nothing.

This article covers the United States, because the prices, the insurance practice and the guideline grades below are all American. Nothing here is medical advice, and none of it replaces a conversation with a clinician who knows your history. Where a test is discussed, the grade quoted describes screening people without symptoms, which is what a package sold to a healthy executive does.

What does an executive health checkup actually cost?

Two peer-reviewed surveys are the only sources we found that attach prices to named hospital programs, and both describe 2019. A JAMA survey of top-ranked hospitals put package costs at $1,700 to $10,000. A JAMA Internal Medicine survey recorded $995 at Houston Methodist, $2,500 at Brigham and Women's, $5,000 to $11,000 at Mayo Clinic and $5,000 to $15,000 at Cleveland Clinic, whose Premier program reached $25,000.

The 2019 survey in JAMA examined 50 top-ranked hospitals and found that 32 of them, 64 percent, offered executive physical packages, with service information available for 29 hospitals across 46 unique packages. Its price sentence is short: "Package costs ranged from $1700 to $10 000."

The 2020 survey in JAMA Internal Medicine went narrower and deeper, covering 25 top-ranked cardiology and heart surgery hospitals, of which 21 responded and 18 offered 28 executive screening programs, surveyed by phone in 2019. It recorded what those programs contained as well as what they cost: 71 percent included a lipid panel, 68 percent a cardiac stress test and 43 percent cardiac CT.

Treat the hospital figures as historical. They were collected for research in 2019, the hospitals have not republished them, and none of those four prints a price today.

Why is the price so hard to find?

Because most programs choose not to publish one. Of the US programs we checked, most list contents, duration and hospitality details but no figure, while only Greenbrier Clinic at $3,500 cash, Hoag at $3,175 and My Doctor Medical Group in San Francisco from $12,500 print a price on their own pages. Any range that does not name a hospital and a study is an estimate, not a price.

The programs that stay silent are open about why. Scripps says the cost of its examination depends on factors such as your age, gender, medical history and individual risk profile. The Mayo Clinic FAQ explains coverage and logistics at length and gives no figure, and Inova asks you to request a quote.

Northwestern Medicine, Mass General Brigham, Duke, Atlantic Health System, Ochsner, Mount Sinai, Froedtert and RWJBarnabas publish no figure either. The exception among the hospital systems we checked is Hoag, which lists its executive physical at $3,175.

Two programs publish adjacent numbers without publishing the price itself. Emory publishes cancellation fees of $250, $500 and $750 depending on notice. Inova publishes a $500 reservation fee applied to a balance it does not state.

What is inside the package, and what do the guidelines say?

The two items bundled most often are a hearing examination and an electrocardiogram, each offered by 83 percent of the hospitals in a 2019 JAMA survey, which also found four services graded D by the US Preventive Services Task Force among the contents. Resting or exercise ECG is graded D in adults without symptoms at low cardiovascular risk. Coronary artery calcium, hsCRP and the ankle-brachial index added to standard risk assessment are graded I, meaning the evidence is insufficient.

The 2019 JAMA survey put it plainly: "Four grade D services were included, 2 of which were graded I for specific subpopulations." Those four were carotid ultrasound, electrocardiogram, stress testing and pulmonary function testing. Services with insufficient evidence designations "were frequently included", which the authors warned "could promote excessive, low-value care", because inclusion by a top-ranked center "may be interpreted as endorsement of their importance".

Here is how the common contents line up against the US Preventive Services Task Force. Grades A and B mean recommended. Grade C means offered selectively, as an individual decision. Grade D means recommended against. Grade I means the evidence is insufficient to weigh benefits against harms.

Two caveats. A grade I is not a verdict that a test is useless, it is a statement that the evidence does not settle the question, and a clinician can still have a good individual reason to order one. And every grade above describes screening people without symptoms, so the same test ordered because of a symptom or a known condition is a different decision.

The lipid row needs its own sentence. The Task Force grades statin use, not a lipid test: grade B for adults 40 to 75 with at least one cardiovascular risk factor and an estimated 10-year risk of 10 percent or more, which is assessed with a lipid panel. For which screenings apply at your own age, sex and risk profile, our screening tool maps the published guidelines rather than restating them here.

What would the same tests cost if you ordered them yourself?

Between $189 and $399 for a large panel, and under $100 each for the handful of blood tests behind grade A or B recommendations. Labcorp OnDemand publishes a Comprehensive Health Test at $189 and Quest an Elite Health Profile at $399 plus a physician fee from $6, and annual testing memberships sit in the same band, with Function Health at $365 a year and Superpower at $349.

Prices below were read on the sellers' own pages on 1 October 2026, and they change. Labcorp OnDemand was running a 25 percent sale that day, so its regular prices are given. Quest adds a physician service fee starting at $6 at checkout, so a listed Quest price understates the total.

The Comprehensive Health Test at $189 bundles a comprehensive metabolic panel, a complete blood count with differential, a urinalysis, a lipid panel and HbA1c. Function Health advertises "160+ lab tests" a year across two rounds of testing, and Superpower "150+ lab tests across 2 blood draws". Function Health and Marek Diagnostics do not serve every state, and neither membership includes a physical examination or a clinician deciding which results matter for you.

Which parts of the package can you not buy on your own?

Three things: imaging and stress testing, which need a clinician's order in a way blood work usually does not, extended physician time, which the programs themselves put at anywhere from up to an hour to four hours or more, and same-day coordination with specialist access if something turns up. The first has modest published self-pay prices, while the second and third have no price list at all and are what the package premium actually pays for.

The first is a real friction rather than a manufactured one. Blood work self-orders in a few clicks at Quest or Labcorp OnDemand, with Quest charging a physician service fee for the order, though availability varies by location. Imaging and stress testing generally need an order. Where self-pay prices for those are published they are modest: $150 at Duke for CT cardiac calcium scoring, a $165 national average on MDsave, which states a range of $48 to $397, $125 at UAB for a diagnostic exercise test with 12-lead ECG, and from $39.95 at BodySpec for a DEXA body composition scan. Prenuvo publishes $2,499 for a whole body MRI, and its executive package starts at $3,999.

The second is the one specification worth comparing directly between offers, because the programs state it. Cooper Clinic says its exam typically lasts "six to eight hours and includes up to one hour of doctor-patient interaction". RWJBarnabas advertises 90 minutes of one-on-one physician contact. My Doctor Medical Group states four or more hours of physician time. No lab membership includes any of it.

The third is scheduling. Cleveland Clinic described six to eight hours in a day on an archived version of its exam page. A Mayo Clinic visit typically takes two days, sometimes one or three. Princeton Longevity Center tells patients to plan on about seven hours. If a finding needs a specialist, these programs have internal pipelines, and assembling the equivalent yourself means separate appointments over weeks.

Does a comprehensive checkup make you live longer?

Not at population level. The Cochrane review of general health checks, covering 17 trials and 251,891 participants, concluded that they are unlikely to be beneficial, with high-certainty evidence of no effect on total mortality, and the Society of General Internal Medicine advises against routine general health checks for adults without symptoms. Individual screenings with grade A or B recommendations are a separate matter, and those do have evidence behind them.

The Cochrane review, published in January 2019, defined a health check as "screening for more than one disease or risk factor in more than one organ system", which is a fair description of an executive physical. It included 17 trials, 15 of them reporting outcome data on 251,891 participants. Its authors' conclusion is one sentence: "General health checks are unlikely to be beneficial."

The numbers behind that sentence: no effect on total mortality, risk ratio 1.00 with a confidence interval of 0.97 to 1.03 across 11 trials, 233,298 participants and 21,535 deaths, rated high-certainty evidence. No effect on cancer mortality, risk ratio 1.01 with an interval of 0.92 to 1.12. Probably no effect on cardiovascular mortality, risk ratio 1.05 with an interval of 0.94 to 1.16, rated moderate-certainty.

The Society of General Internal Medicine's Choosing Wisely recommendation is blunter: do not perform routine general health checks for asymptomatic adults. Its rationale, reproduced by the American Academy of Family Physicians, is that such visits "have not shown to be effective in reducing morbidity, mortality or hospitalization, while creating a potential for harm from unnecessary testing". A Department of Veterans Affairs evidence brief reached the same place: "Comprehensive routine physical examinations are not recommended for the asymptomatic adult".

None of that argues against the individual screenings with grade A or B recommendations. Those work. It argues against the bundle as a strategy, and how much of a routine physical is recommended at all differs by country, as our piece on what an annual physical includes in different countries sets out.

What does an unnecessary finding cost you?

Often more than the test did. The American College of Radiology says there is not sufficient evidence to justify recommending total body screening for people without symptoms, risk factors or relevant family history, and that it produces non-specific findings leading to unnecessary follow-up and expense. A systematic review of 5,373 people without symptoms put critical and indeterminate incidental findings together at 32.1 percent, with a confidence interval of 18.3 to 50.1 percent.

The college's statement on screening total body MRI, dated April 2023, warns of "numerous non-specific findings that will not ultimately improve patients' health but will result in unnecessary follow-up testing and procedures, as well as significant expense". The FDA states it "knows of no scientific evidence demonstrating that whole-body scanning of individuals without symptoms provides more benefit than harm".

The incidental-findings figure comes from a 2019 systematic review pooling 12 studies across 5,373 asymptomatic subjects. Read it carefully rather than as a headline: the confidence interval runs from 18.3 to 50.1 percent and the studies disagreed widely, so the defensible reading is that a substantial minority of healthy people who get scanned end up with something to chase, not that the rate is precisely one in three.

The American College of Preventive Medicine's Choosing Wisely list compresses all of it into one line: do not use whole-body scans for early tumor detection in asymptomatic patients, because "there are no data suggesting that these imaging studies will result in improved morbidity or mortality". If a package leads with whole-body imaging, these are the documents to raise with the clinician offering it.

Will insurance pay for an executive physical?

Mostly no. Emory, Scripps and Princeton Longevity Center state they are self-pay or take no insurance, Johns Hopkins omits procedure and diagnosis codes from its invoices so they cannot be submitted for reimbursement, and Cleveland Clinic says many carriers cover a very small portion. Mayo Clinic is the outlier, stating that the majority of a visit is typically covered, while noting that coverage varies by plan.

The Johns Hopkins line is the one to sit with. Its FAQ says it does not bill your health insurance provider, and that since 1 July 2021 its invoices carry no CPT or diagnosis codes, so patients cannot submit them to an insurer for reimbursement. A program that does that is telling you plainly which side of the covered-care line it sits on.

Separately from any of this, a US plan already covers a defined set of preventive services at no cost to you, and those are the same grade A and B recommendations from the table above. Establishing what your own plan already pays for is a cheaper first move than buying a package, and it is a different exercise from this one.

So who is an executive physical worth it for?

For people who have not had preventive care in years, who cannot realistically attend four appointments across two months, who have a family history that deserves an unhurried hour, who need imaging coordinated in one place, or whose employer is paying. Skip it when the headline feature is the number of biomarkers, when whole-body imaging leads the offer, or when what you actually want is the data, which costs a few hundred dollars.

Two or more of the first set being true is a reasonable threshold. One of the second set being true is usually enough to walk away, and the biomarker-count pitch is the clearest signal of the three, because it is the specification that correlates least with the grades in the table above.

The table below puts the routes side by side, including keeping the results, which every route leaves to you. As a disclosure, Longetic is our product, so weigh the first row accordingly.

Whichever route you take, the output is a document that becomes your problem. A $5,000 package produces a bound summary that goes in a drawer, and a $189 panel produces a portal login you will forget. Next year's numbers arrive from a different laboratory with a different reference range, and the comparison that would have made either purchase worth something, this marker against the same marker a year earlier, never gets made. Several apps cover parts of that job, and our comparison of apps for tracking blood test results over time goes through them product by product.

And if the question you arrived with was which screenings you are due for, start with the screening tool and the Task Force recommendations rather than with a package.

Frequently asked questions